Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Catherine, Terret"'
Autor:
Mylène Annonay, MD, Lisa Gauquelin, MD, Romain Geiss, MD, Mony Ung, MD, Laurence Cristol-Dalstein, MD, Marie-Ange Mouret-Reynier, MD PHD, Anthony Goncalves, MD PHD, Sophie Abadie-Lacourtoisie, MD, Eric Francois, MD, Christophe Perrin, MD, Johan Le Fel, MD, Véronique Lorgis, MD, Véronique Servent, MD, Lionel Uwer, MD, Christelle Jouannaud, MD, Marianne Leheurteur, MD, Florence Joly, MD PHD, Loic Campion, MD, Coralie Courtinard, MPH, Olivier Villacroux, MD, Thierry Petit, MD PHD, Pierre Soubeyran, MD, Catherine Terret, MD, Carine Bellera, PHD, Etienne Brain, MD PHD, Suzette Delaloge, MD MPH
Publikováno v:
Breast, Vol 60, Iss , Pp 138-146 (2021)
Background: Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. Methods: Women who initi
Externí odkaz:
https://doaj.org/article/ade3e6c3b78e4adab88c10f438f12991
Autor:
Philippe A. Cassier, Clémentine Peyramaure, Valery Attignon, Lauriane Eberst, Camille Pacaud, Sandrine Boyault, Françoise Desseigne, Mathieu Sarabi, Pierre Guibert, Pauline Rochefort, Nathalie Marques, Michel Rivoire, Aurélien Dupré, Patrice Peyrat, Catherine Terret, Isabelle Ray-Coquard, Clélia Coutzac, David Pérol, Jean-Yves Blay, Olivier Trédan, Christelle de la Fouchardière
Publikováno v:
Translational Oncology, Vol 15, Iss 1, Pp 101266- (2022)
Background: Chemotherapy, anti-HER2 and PD-1 antibodies are standard treatments but only a minority of patients derive long-term benefit from these agents. Methods: In this report we describe the mutational landscape and outcome of patients with gast
Externí odkaz:
https://doaj.org/article/af51f8a698dc4ce7a25e81ac463e3700
Autor:
Pauline Corbaux, Catherine Terret, Claire Cropet, Sylvie Chabaud, Chiara Russo, Christelle Faure, Olivier Tredan, Thomas Bachelot, Pierre-Etienne Heudel
Publikováno v:
International Journal of Clinical Oncology. 28:371-381
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f3e6d72a0d153c7a2ec5a67c0a3d6b0
https://doi.org/10.1007/s10147-023-02296-z
https://doi.org/10.1007/s10147-023-02296-z
Autor:
Aurélien Voissière, Carlos Gomez-Roca, Sylvie Chabaud, Céline Rodriguez, Axelle Nkodia, Justine Berthet, Laure Montane, Anne-Sophie Bidaux, Isabelle Treilleux, Lauriane Eberst, Catherine Terret, Iphigénie Korakis, Gwenaelle Garin, David Pérol, Jean-Pierre Delord, Christophe Caux, Bertrand Dubois, Christine Ménétrier-Caux, Nathalie Bendriss-Vermare, Philippe A. Cassier
Tumor-associated macrophages (TAM) are critical determinant of resistance to programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) blockade. This phase I study (MEDIPLEX,NCT02777710) investigated the safety and efficacy of pexidartinib, a CSF-1R-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d8995e7196aabc5b93b82d406400d13
https://doi.org/10.1101/2023.02.15.23285939
https://doi.org/10.1101/2023.02.15.23285939
Autor:
Carlos Gomez-Roca, Philippe Cassier, Dmitriy Zamarin, Jean-Pascal Machiels, Jose Luis Perez Gracia, F Stephen Hodi, Alvaro Taus, Maria Martinez Garcia, Valentina Boni, Joseph P Eder, Navid Hafez, Ryan Sullivan, David Mcdermott, Stephane Champiat, Sandrine Aspeslagh, Catherine Terret, Anna-Maria Jegg, Wolfgang Jacob, Michael A Cannarile, Carola Ries, Konstanty Korski, Francesca Michielin, Randolph Christen, Galina Babitzki, Carl Watson, Georgina Meneses-Lorente, Martin Weisser, Dominik Rüttinger, Jean-Pierre Delord, Aurelien Marabelle
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol. 10, no.5, p. e004076 (2022)
BackgroundThis phase 1b study (NCT02323191) evaluated the safety, antitumor activity, pharmacokinetics, and pharmacodynamics of colony-stimulating factor-1 receptor-blocking monoclonal antibody (mAb) emactuzumab in combination with the programmed cel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2c2dc4accf632390ea464a967fc522a
https://pubmed.ncbi.nlm.nih.gov/35577503
https://pubmed.ncbi.nlm.nih.gov/35577503
Autor:
Maud Cecile, Louis Tassy, Cecile Braticevic, Catherine Terret, Matthieu Sarabi, Gilles Albrand, Emilien Billon, Frédérique Rousseau
Publikováno v:
Journal of Geriatric Oncology. 11:536-539
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deeec5b96e2e93dc431217d8e3d970a2
https://doi.org/10.1016/j.jgo.2019.07.015
https://doi.org/10.1016/j.jgo.2019.07.015
Autor:
Cassandre Gluszak, Loïc Campion, Valérie Seegers, Oana Cojocarasu, Jean-Marie Commer, Frank Priou, Frédéric Rolland, Catherine Terret, Sophie Abadie-Lacourtoisie
Publikováno v:
Journal of Clinical Medicine. 12:1636
Geriatric assessment (GA) can predict and improve treatment tolerance and estimate overall survival in older patients with cancer. Several international organizations promote GA; however, data related to its implementation in daily clinical practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26d1a99e312340dcfa57e78e1d966f7e
https://doi.org/10.3390/jcm12041636
https://doi.org/10.3390/jcm12041636
Autor:
Carine Bellera, Christophe Perrin, Sophie Abadie-Lacourtoisie, Lisa Gauquelin, Marianne Leheurteur, Eric Francois, Catherine Terret, V. Servent, Romain Geiss, Veronique Lorgis, Christelle Jouannaud, Lionel Uwer, Suzette Delaloge, Anthony Gonçalves, Mony Ung, Etienne Brain, Thierry Petit, Olivier Villacroux, Florence Joly, Mylène Annonay, Coralie Courtinard, Pierre Soubeyran, Laurence Cristol-Dalstein, Johan Le Fel, Loïc Campion, Marie-Ange Mouret-Reynier
Publikováno v:
Breast
Breast, Elsevier, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Breast, Vol 60, Iss, Pp 138-146 (2021)
The Breast : Official Journal of the European Society of Mastology
Breast, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Breast, Elsevier, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Breast, Vol 60, Iss, Pp 138-146 (2021)
The Breast : Official Journal of the European Society of Mastology
Breast, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩
Background Treatment and outcomes of patients with HER2-positive (HER2+) metastatic breast cancer (MBC) have dramatically improved over the past 20 years. This work evaluated treatment patterns and outcomes according to age. Methods Women who initiat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e3731ff80e1c38ffc118a60fc7423c5
https://hal.archives-ouvertes.fr/hal-03468488/file/BPH_TB_2021_Annonay.pdf
https://hal.archives-ouvertes.fr/hal-03468488/file/BPH_TB_2021_Annonay.pdf
Autor:
Baptiste Fournier, Olivia Pérol, Chiara Russo, Lidia Delrieu, Catherine Terret, Béatrice Fervers
Publikováno v:
European journal of cancer careREFERENCES. 31(1)
OBJECTIVE The objective of this study is to assess the physical activity interest and preferences of cancer patients aged over 70 years during oncological treatments and to explore how demographic characteristics may modulate preferences. METHODS Fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab13445bb23448b5729c29fa00c9545
https://pubmed.ncbi.nlm.nih.gov/34668267
https://pubmed.ncbi.nlm.nih.gov/34668267
Autor:
Pierre Soubeyran, Carine Bellera, Jean Goyard, Damien Heitz, Hervé Curé, Hubert Rousselot, Gilles Albrand, Véronique Servent, Olivier Saint Jean, Isabelle van Praagh, Jean-Emmanuel Kurtz, Stéphane Périn, Jean-Luc Verhaeghe, Catherine Terret, Christophe Desauw, Véronique Girre, Cécile Mertens, Simone Mathoulin-Pélissier, Muriel Rainfray
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e115060 (2014)
Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify th
Externí odkaz:
https://doaj.org/article/a536cf37e8894c099973422c3907d4e0